In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I
Open Access
- 1 January 1991
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (1) , 203-207
- https://doi.org/10.1128/aac.35.1.203
Abstract
The activity of LJC10,627 was compared with the activities of imipenem and other antibiotics. LJC10,627 was more active against most members of the family Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. but slightly less active than imipenem against staphylococci and streptococci. LJC10,627 showed stability to mouse dehydropeptidase I and was more effective in vivo than imipenem plus cilastatin against gram-negative bacterial infections and as effective against staphylococcal infections.Keywords
This publication has 5 references indexed in Scilit:
- Imipenem: A New Carbapenem AntibioticMedical Clinics of North America, 1988
- In vitro and pharmacokinetic properties of the carbapenemsAntimicrobial Agents and Chemotherapy, 1986
- Efficacy and Safety of Imipenem/Cilastatin: A Review of Worldwide Clinical ExperienceClinical Infectious Diseases, 1985
- Thienamycin: development of imipenem-cilastatinJournal of Antimicrobial Chemotherapy, 1983
- The purification and properties of a particulate renal dipeptidaseBiochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation, 1966